Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3
Authors:
- 1 July 2011
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (7) , 1162-1168
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancerLung Cancer, 2010
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancerBMC Cancer, 2009
- Clinical importance of B7-H3 expression in human pancreatic cancerBritish Journal of Cancer, 2009
- Fine tuning the immune response through B7‐H3 and B7‐H4Immunological Reviews, 2009
- Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T CellsThe Journal of Immunology, 2009
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2008
- The contrasting role of B7-H3Proceedings of the National Academy of Sciences, 2008
- Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesProceedings of the National Academy of Sciences, 2008
- Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cellsLung Cancer, 2007
- Tolerogenic dendritic cells and regulatory T cells: A two-way relationshipJournal of Dermatological Science, 2007